Sentry BioPharma Services is pleased to announce delegates from Sentry’s Business Development team will be in New York City attending the Drug, Chemical & Associated Technologies Association (DCAT) Week March 19th -22nd. The four-day conference brings together key sourcing, procurement and business...
Monday, March 19, 2018 | Read More
In a press release issued on August 1, 2017, The European Medicines Agency (EMA) announced that it “has developed and initiated a business continuity plan to deal with the uncertainty and workload implications linked to the United Kingdom's (UK's) withdrawal from the European Union (EU) and the Agency's...
Thursday, August 3, 2017 | Read More
Sentry BioPharma Services provides drug product management, global drug distribution, GMP storage and specialized services like pharmaceutical labeling, packaging and kitting. Sentry plays a critical role in protecting temperature-sensitive product safety, identity, strength, purity and quality (SISPQ)...
Monday, July 31, 2017 | Read More
Sophisticated physical and data security measures protect valuable information, pharmaceutical materials, and products while in Sentry's possession. Sentry deploys a robust security program based on industry best practices, market trends, agency intelligence and audit feedback. Sentry maintains steadfast control over product classifications and locations, with segregation capabilities for labeling, returns, quarantine, and controlled substances as well as enhanced security and anti-counterfeiting measures for high-value products. Security measures inside and outside the facility protect, monitor and control access.
Sentry's Pharmaceutical Supply Chain Security: